NIH awards Boston-based Quanterix $20 million for COVID-19 blood test
Many people have either had or at least seen how people are tested for the coronavirus.A Massachusetts company is looking to replace nasal swap tests with simple blood tests. Boston-based Quanterix was awarded a $20 million contract by the National Institutes of Health to see if their blood test for COVID-19 is more accurate than the current nasal swap test. “There’s a big concern that there’s a lot of false negatives occurring, particularly for asymptomatic,” Kevin Hrusovsky, the president and CEO of Quanterix said. “People who don’t have symptoms, many times are being told they don’t have the virus, when in fact they do.”Quanterix calls itself a diagnostic technology company. Its specialty is to test blood markers in patients and find out what disease or illness they have long before symptoms ever arise. Now, the government is investing millions in companies like Quanterix in the battle against COVID-19. “We can actually get the blood from a finger prick, which is a very non-invasive, and potentially a home care way to get that answer,” Hrusovsky said.
Many people have either had or at least seen how people are tested for the coronavirus.
A Massachusetts company is looking to replace nasal swap tests with simple blood tests.
Boston-based Quanterix was awarded a $20 million contract by the National Institutes of Health to see if their blood test for COVID-19 is more accurate than the current nasal swap test.
“There’s a big concern that there’s a lot of false negatives occurring, particularly for asymptomatic,” Kevin Hrusovsky, the president and CEO of Quanterix said. “People who don’t have symptoms, many times are being told they don’t have the virus, when in fact they do.”
Quanterix calls itself a diagnostic technology company. Its specialty is to test blood markers in patients and find out what disease or illness they have long before symptoms ever arise. Now, the government is investing millions in companies like Quanterix in the battle against COVID-19.
“We can actually get the blood from a finger prick, which is a very non-invasive, and potentially a home care way to get that answer,” Hrusovsky said.
Read More: NIH awards Boston-based Quanterix $20 million for COVID-19 blood test